Clinical Trial Update: An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

View source ↗

Summary

Observational study update (FINEGUST) examining how chronic kidney disease and type 2 diabetes are treated and the impact of introducing finerenone on clinical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus | Status: COMPLETED